Insiders Roll Over Equity as Select Medical Completes Take-Private Merger and Delists

summarizeSummary

This Schedule 13D/A confirms that key insiders, including Robert A. Ortenzio and Martin F. Jackson, no longer beneficially own shares of Select Medical Holdings Corp following its take-private merger and delisting from the NYSE. Their shares were rolled over into equity interests in the new private parent entity.

check_boxKey Events · Ownership and Investor Activity · SEM

• Merger Completion Confirmed

  Select Medical Holdings Corp. completed its take-private merger on July 1, 2026, at $16.50 per share, as previously announced.

• Delisting from NYSE

  The company's common stock ceased trading and was delisted from the New York Stock Exchange as of July 1, 2026.

• Insider Rollover Agreements

  Key reporting persons, including Robert A. Ortenzio and Martin F. Jackson, exchanged their public shares for equity interests in the new private parent entity, confirming their continued investment in the company post-merger.

• Exit Filing

  This amendment serves as an exit filing for the reporting persons, indicating they no longer beneficially own shares in the publicly traded entity.

auto_awesomeAnalysis · SEM · Industrial Applications And Services

This filing provides the final regulatory update on the beneficial ownership of key insiders following Select Medical Holdings Corp.'s take-private merger. While the merger completion and delisting were previously announced, this Schedule 13D/A specifically details that Robert A. Ortenzio, Martin F. Jackson, and the Estate of Rocco A. Ortenzio no longer hold public shares, having rolled over their equity into the new private parent company. This confirms their continued commitment to the company's future, albeit in a private capacity, and finalizes their reporting obligations for the now-delisted public entity.